IL6ST and inflammatory bowel disease: Another small molecule inhibitor LMT-28 (a derivative of oxazolidinone) was recently demonstrated to suppress IL-6 signaling by directly binding gp130, resulting in alleviation of inflammatory diseases such as RA and inflammatory bowel disease (69).